PredictrPK (R) ADA, a Precision-Guided Dosing Test Supporting Adalimumab Treatment Optimization, Demonstrates Strong Clinical Utility in New Study Provided by ACCESS Newswire Jun 17, 2025, 5:00:00 AM ...

Mean T 4 concentrations before dosing were approximately 7.5 µg/dL and reached a maximum of 13 to 14 µg/dL before declining. By 96 hours, mean T 4 concentrations decreased to approximately 9 µg/dL.

Initial Data from the Ongoing, Blinded Phase 1 Single-Ascending Dose Trial Has Demonstrated Favorable Safety and Pharmacokinetics IND Application Submitted to Expand RESTORE-FA Trial to U.S. Sites ...

CHICAGO—Compounded oral liquid levothyroxine products vary in stability, potency and consistency and present risks for patients, according to data presented the American Thyroid Association ...